Category: Today’s Highlights
Midday January 16, 2020 Outperforming Prohost Picks
Outperforming Prohost Picks January 16, 2020 at 11:30 am EST MRNA Trading at $21.35 UP $1.01 AMGN Trading at $243.50 UP $1.80 FTSV Trading at $40.00 UP $3.20 RETA Trading at $217.01 UP $4.56 ALNY Trading at $119.26 UP $1.17...
Read More
January 16, 2020
0
Vertex has good news from Australia. Why selling solid firms stocks.
Vertex Pharmaceuticals (VRTX) announced that the Pharmaceutical Benefits Advisory Committee’s (PBAC) in Australia recommendation the listing of Orkambi ® (lumacaftor/ivacaftor) on the Pharmaceutical Benefits Scheme (PBS). The recommendation is for cystic fibrosis people ages six and over who have two...
Read More
August 21, 2018
0
Why Moderna Stock Is Rallying
In the NEWS: Coronavirus Yesterday the CDC announced the first US case of coronavirus which has killed 17 and sickened hundreds of people in China. According to officials the first US case is of a very healthy 30 year old...
Read More
January 22, 2020
0
Starting the gene therapy chapter in the book of the biotech revolution
WE ARE LIVING AN HISTORIC BIOLOGICAL REVOLUTION . Unfortunately, the undeniably outstanding news has not yet penetrated the ears of many investors. They are still falling victim to the stock market traders’ games and to critics’ and bloggers’ magnifications or...
Read More
August 22, 2018
0
The Medicines Company Has Agreeable News
The Medicines Company The Medicines Company ( MDCO ) focuses on cardiovascular diseases. Major goals are halting the progression of atherosclerosis and lowering the cardiovascular risk caused by high levels of LDL Cholesterol ( LDL-C ). The firm announced good...
Read More
August 27, 2019
0
Gene Therapy and Other Treatments That Work at the Genetic Level
Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of the stocks from companies specialized in gene therapy, gene editing, antisense, RNAi and mRNA therapies. Recently, bluebird bio’s ( BLUE ) stock was devastated....
Read More
August 30, 2019
0
The European Medicine Agency Validates the Gilead Application for a CAR T Product for Mantle Cell Lymphoma
The EMA validated the MAA for the Gilead Investigational CAR T Product for MCL Kite , a Gilead ( GILD ) company, announced that the European Medicines Agency ( EMA ) has validated the Marketing Authorization Application ( MAA )...
Read More
January 29, 2020
0
About Portola
Portola (PTLA) has two important approved breakthrough products and an investigational product having promising results on very difficult-to-treat cancers . Instead of soaring following the approval of its two drugs and the good results coming from the investigational third drug,...
Read More
August 27, 2018
0
Vertex: In Pursuit of Cures
Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical ( VRTX ) entered into a definitive agreement to buy a private company, Semma Therapeutics. Semma uses stem cell-derived human islets as a potential cure for type 1 diabetes. Semma’s major scientific advances...
Read More
September 4, 2019
0
Amgen's Oncology Product AMG-510 Meeting An Unmet Need for Kras G12C Mutated Cancers
Amgen's Outperforming After being boxed in, for the past couple of weeks, Amgen’s ( AMGN ) stock finally outperformed. The firm was outperforming silently with regard to its financial results, sciences, technologies, pipeline products and multiple newly approved products drugs. ...
Read More
September 9, 2019
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)